Stelma, Femke
de Niet, Annikki
Sinnige, Marjan J.
van Dort, Karel A.
van Gisbergen, Klaas P. J. M.
Verheij, Joanne
van Leeuwen, Ester M. M.
Kootstra, Neeltje A.
Reesink, Hendrik W.
Article History
Received: 16 January 2017
Accepted: 12 June 2017
First Online: 21 July 2017
Competing Interests
: Hendrik W. Reesink serves as a consultant for AbbVie, Alnylam, Bristol Myers Squibb, Gilead Sciences, Janssen-Cilag, Merck, PRA International, Regulus, Replicor, Roche and R-Pharm and received grant/research support from AbbVie, Bristol Myers Squibb, Boehringer Ingelheim, Gilead Sciences, Janssen-Cilag, Merck, PRA International, Regulus, Replicor and Roche. All other authors: None declared.